Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 05, 2015 10:01 AM ET


Company Overview of Quanterix Corporation

Company Overview

Quanterix Corporation develops and provides ultra-sensitive diagnostic platform for measuring individual proteins. The company offers Single Molecule Array technology that enables the detection and quantification of biomarkers in life science research, in-vitro diagnostics, companion diagnostics, blood screening, and more; assay kits; and consumables. Its products are used in life science research, oncology, neurology, inflammatory disease, and infectious disease applications. Quanterix Corporation was formerly known as Digital Genomics Inc. and changed its name to Quanterix Corporation in August 2007. The company was founded in 2007 and is based in Lexington, Massachusetts.

13 Hartwell Avenue

Suite B14201

Lexington, MA 02421

United States

Founded in 2007





Key Executives for Quanterix Corporation

Executive Chairman and Chief Executive Officer
President and Director
Co-Founder, Chairman of Scientific Advisory Board and Director
Age: 61
Chief Financial Officer and Vice President of Finance & Administration
Chief Technology Officer and Vice President of Research
Compensation as of Fiscal Year 2014.

Quanterix Corporation Key Developments

Quanterix Appoints SCRUM Inc. for Simoa Distribution in Japan

Quanterix Corporation announced it has appointed SCRUM Inc. as an exclusive distributor for sales and support of its Simoa technology for the research market in Japan.

Myriad RBM Uses Quanterix’ Simoa Technology to Launch New Ultrasensitive Immunoassay Services

Quanterix Corporation announced that Myriad RBM will use Quanterix' Simoa technology to launch new ultrasensitive immunoassay services in its CLIA-certified laboratory in Austin, Texas. Using Simoa, the company will have the ability to accurately measure protein biomarkers that were previously difficult or even impossible to detect in blood samples.

Quanterix Corporation Appoints Kevin Hrusovsky as Chief Executive Officer

Quanterix Corporation announced the appointment of Kevin Hrusovsky as Chief Executive Officer (CEO). Mr. Hrusovsky will continue to serve as Executive Chairman of its Board of Directors. Kevin Hrusovsky brings over 20 years of experience in life science and diagnostics industries with a strong track record for innovation and commercializing disruptive technologies. Prior to joining Quanterix, he was President of Life Sciences and Technologies at PerkinElmer.

Similar Private Companies By Industry

Company Name Region
Battelle Biomedical Research Center United States
DermTech, Inc. United States
Xcell Biosciences, Inc. United States
Oricula Therapeutics LLC United States
HairDX, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Quanterix Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at